BTIG analyst Ryan Zimmerman lowered the firm’s price target on Tactile Systems to $19 from $22 but keeps a Buy rating on the shares. The company’s tax benefit drove its Q3 earnings beat, while the double-digit growth in lymphedema was hampered by Airway Clearance sales decline, the analyst tells investors in a research note. Tactile Systems is still able to maintain its long-term growth and profitability targets however, and its Airway Clearance challenges will ultimately prove transitory, the firm added.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on TCMD:
- Tactile Systems price target lowered to $23 from $30 at Piper Sandler
- Tactile Systems Technology, Inc. Reports Third Quarter 2023 Financial Results; Updates Full Year 2023 Outlook
- Is TCMD a Buy, Before Earnings?
- Tactile Medical to Release Third Quarter of Fiscal Year 2023 Financial Results on November 6, 2023
- Tactile Medical Appoints Vindell Washington, M.D. to Board of Directors
